Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,684 | 868 | 86.2% |
| Unspecified | $2,015 | 11 | 9.8% |
| Education | $687.57 | 9 | 3.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $135.24 | 1 | 0.7% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,077 | 218 | $0 (2024) |
| SANOFI US SERVICES INC. | $2,015 | 11 | $0 (2023) |
| Janssen Biotech, Inc. | $1,797 | 99 | $0 (2024) |
| LEO Pharma Inc. | $1,148 | 51 | $0 (2024) |
| Lilly USA, LLC | $1,146 | 59 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,090 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,085 | 53 | $0 (2024) |
| GENZYME CORPORATION | $1,007 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $993.30 | 43 | $0 (2024) |
| PFIZER INC. | $936.96 | 51 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,015 | 305 | ABBVIE INC. ($1,013) |
| 2023 | $5,364 | 151 | SANOFI US SERVICES INC. ($2,015) |
| 2022 | $5,294 | 248 | ABBVIE INC. ($1,562) |
| 2021 | $3,848 | 185 | AbbVie Inc. ($897.77) |
All Payment Transactions
889 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $10.12 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $17.74 | General |
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.56 | General |
| Category: Immunology | ||||||
| 12/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $9.89 | General |
| Category: ACNE | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.98 | General |
| Category: Immunology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Immunology | ||||||
| 11/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: DERMATOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: Immunology | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Immunology | ||||||
| 11/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $9.13 | General |
| Category: DERMATOLOGY | ||||||
| 11/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Efficacy, Safety, PK, Biologics Monotherapy Study in Pts. with Moderate to Severe AD | SANOFI US SERVICES INC. | $2,015 | 11 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,418 | 2,415 | $507,265 | $83,977 |
| 2022 | 9 | 523 | 846 | $67,900 | $32,955 |
| 2021 | 9 | 588 | 908 | $78,415 | $38,880 |
| 2020 | 5 | 74 | 118 | $7,340 | $3,564 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 324 | 377 | $114,231 | $21,385 | 18.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 186 | 213 | $94,998 | $15,980 | 16.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 163 | 163 | $68,297 | $11,161 | 16.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 249 | 272 | $73,440 | $10,015 | 13.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 193 | 1,055 | $37,980 | $4,615 | 12.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 31 | 37 | $21,978 | $4,213 | 19.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 89 | 106 | $20,034 | $3,932 | 19.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 53 | 54 | $21,168 | $3,424 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 31 | $13,392 | $2,527 | 18.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 54 | 54 | $16,794 | $2,463 | 14.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $12,065 | $2,030 | 16.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 18 | $9,000 | $1,574 | 17.5% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2023 | 15 | 16 | $3,888 | $657.61 | 16.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 155 | 209 | $20,900 | $11,033 | 52.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 82 | 111 | $14,430 | $7,941 | 55.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 62 | 62 | $9,300 | $3,956 | 42.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 72 | 91 | $8,190 | $3,042 | 37.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 48 | 55 | $4,125 | $2,010 | 48.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 17 | $2,040 | $1,491 | 73.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 20 | 22 | $2,640 | $1,386 | 52.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 49 | 257 | $3,855 | $1,176 | 30.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 22 | 22 | $2,420 | $921.12 | 38.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 160 | 230 | $23,000 | $12,784 | 55.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 88 | 118 | $15,340 | $8,637 | 56.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 87 | 87 | $13,050 | $5,697 | 43.7% |
About Evelyn Stein
Evelyn Stein is a Physician Assistant healthcare provider based in Lincoln, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1134759418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Evelyn Stein has received a total of $20,522 in payments from pharmaceutical and medical device companies, with $6,015 received in 2024. These payments were reported across 889 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($17,684).
As a Medicare-enrolled provider, Stein has provided services to 2,603 Medicare beneficiaries, totaling 4,287 services with total Medicare billing of $159,376. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Lincoln, RI
- Active Since 01/25/2020
- Last Updated 02/14/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1134759418
Products in Payments
- RINVOQ (Biological) $1,972
- DUPIXENT (Biological) $1,908
- SKYRIZI (Biological) $1,518
- TREMFYA (Drug) $1,338
- Sotyktu (Drug) $1,043
- OPZELURA (Drug) $920.50
- TALTZ (Drug) $806.88
- ADBRY (Biological) $726.32
- COSENTYX (Biological) $674.72
- EUCRISA (Drug) $602.08
- REMICADE (Biological) $582.92
- Bimzelx (Biological) $576.30
- HUMIRA (Biological) $562.45
- Otezla (Drug) $431.03
- ENSTILAR (Drug) $421.98
- Zoryve (Drug) $409.26
- VTAMA (Drug) $363.03
- Cimzia (Drug) $335.73
- CIBINQO (Drug) $315.88
- Ilumya (Biological) $309.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lincoln
Michelle Sitzman, Pa, PA
Physician Assistant — Payments: $98,547
Ms. Stephanie Marlin, Pa-C, PA-C
Physician Assistant — Payments: $29,832
Alfred Liddle, Pa, PA
Physician Assistant — Payments: $18,396
Laura Tvrdy, Pa-C, PA-C
Physician Assistant — Payments: $14,244
Jacklynn Kment, Pa-C, PA-C
Physician Assistant — Payments: $9,036
Courtney Mares, Pa-C, PA-C
Physician Assistant — Payments: $8,592